The parasomnias: Epidemiology, clinical features, and diagnostic approach

Clinics in Chest Medicine

Volumn 31, Issue 2, 2010, Pages 353-370

  Avidan, Alon Y ^a   Kaplish, Neeraj ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Confusional arousals; Night terrors; Nightmares; Parasomnias; RBD and sleep paralysis; Sleepwalking

Indexed keywords

ANXIOLYTIC AGENT; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; IMIPRAMINE; LEVODOPA; MELATONIN; OXYBATE SODIUM; PAROXETINE; PRAMIPEXOLE; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

BEDTIME DOSAGE; CLINICAL FEATURE; COGNITIVE THERAPY; COUNSELING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG TOLERABILITY; FRONTAL LOBE EPILEPSY; HEREDITY; HUMAN; HYPNOSIS; LOW DRUG DOSE; NIGHTMARE; NONHUMAN; NONREM SLEEP; PARASOMNIA; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RELAXATION TRAINING; REM SLEEP; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SLEEP AROUSAL DISORDER; SLEEP THERAPY; SLEEP WALKING;

AGED; CHILD, PRESCHOOL; DREAMS; EPILEPSY, FRONTAL LOBE; FEMALE; HUMANS; MALE; MIDDLE AGED; NIGHT TERRORS; PARASOMNIAS; POLYSOMNOGRAPHY; REM SLEEP BEHAVIOR DISORDER; SLEEP; SLEEP PARALYSIS; SLEEP-WAKE TRANSITION DISORDERS; WAKEFULNESS;

EID: 77952930694     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2010.02.015     Document Type: Review

References (127)

1. Mahowald M.W., Bornemann M.C., Schenck C.H. Parasomnias. Semin Neurol 2004, 24(3):283-292.
2. Mahowald M.W., Ettinger M.G. Things that go bump in the night: the parasomnias revisited. J Clin Neurophysiol 1990, 7(1):119-143.
3. Brooks S., Kushida C.A. Behavioral parasomnias. Curr Psychiatry Rep 2002, 4(5):363-368.
4. Fisher C., Kahn E., Edwards A., et al. A psychophysiological study of nightmares and night terrors. I. Physiological aspects of the stage 4 night terror. J Nerv Ment Dis 1973, 157(2):75-98.
5. Fisher C., Kahn E., Edwards A., et al. A psychophysiological study of nightmares and night terrors. 3. Mental content and recall of stage 4 night terrors. J Nerv Ment Dis 1974, 158(3):174-188.
6. Klackenberg G. Somnambulism in childhood-prevalence, course and behavioral correlations: a prospective longitudinal study (6-16 years). Acta Paediatr Scand 1982, 71(3):495-499.
7. Ohayon M.M., Guilleminault C., Priest R.G. Night terrors, sleepwalking, and confusional arousals in the general population: their frequency and relationship to other sleep and mental disorders. J Clin Psychiatry 1999, 60(4):268-276. [quiz 277].
8. Ohayon M.M., Caulet M., Priest R.G. Violent behavior during sleep. J Clin Psychiatry 1997, 58(8):369-376. [quiz: 377].
9. Mahowald M.W., Schenck C.H. Non-rapid eye movement sleep parasomnias. Neurol Clin 2005, 23(4):1077-1106. vii.
10. Mahowald MW. Overview of parasomnias. American Academy of Sleep Medicine. 1999 (National Sleep Medicine Course, Westchester (IL)).
11. Tassinari CA, Cantalupo G, Hogl B, et al. Neuroethological approach to frontolimbic epileptic seizures and parasomnias: the same central pattern generators for the same behaviours Rev Neurol (Paris) 2009;165(1):762-8.
12. American Academy of Sleep Medicine The international classification of sleep disorders: diagnostic and coding manual 2005, American Academy of Sleep Medicine, Westchester (IL), p. 139-47. 2nd edition.
13. Shapiro C.M., Trajanovic N.N., Fedoroff J.P. Sexsomnia-a new parasomnia?. Can J Psychiatry 2003, 48(5):311-317.
14. Kotagal S. Parasomnias in childhood. Sleep Med Rev 2009, 13(2):157-168.
15. Ohayon M.M., Priest R.G., Zulley J., et al. The place of confusional arousals in sleep and mental disorders: findings in a general population sample of 13,057 subjects. J Nerv Ment Dis 2000, 188(6):340-348.
16. Guilleminault C., Moscovitch A., Yuen K., et al. Atypical sexual behavior during sleep. Psychosom Med 2002, 64(2):328-336.
17. Roth B., Rechtsch A., Nevsimal S. Hypersomnia with sleep drunkenness. Arch Gen Psychiatry 1972, 26(5):456.
18. Mehlenbeck R., Spirito A., Owens J., et al. The clinical presentation of childhood partial arousal parasomnias. Sleep Med 2000, 1(4):307-312.
19. Sheldon S.H. Parasomnias in childhood. Pediatr Clin North Am 2004, 51(1):69-88. vi.
20. Ebrahim I.O. Somnambulistic sexual behaviour (sexsomnia). J Clin Forensic Med 2006, 13(4):219-224.
21. Pillmann F. Complex dream-enacting behavior in sleepwalking. Psychosom Med 2009, 71(2):231-234.
22. Schenck C.H., Pareja J.A., Patterson A.L., et al. Analysis of polysomnographic events surrounding 252 slow-wave sleep arousals in thirty-eight adults with injurious sleepwalking and sleep terrors. J Clin Neurophysiol 1998, 15(2):159-166.
23. Mahowald MW, Cramer-Bornemann M. NREM sleep-arousal parasomnias. In: Principles and practice of sleep medicine, 4th edition. 2005. p. 889-96.
24. Hublin C., Kaprio J., Partinen M., et al. Prevalence and genetics of sleepwalking: a population-based twin study. Neurology 1997, 48(1):177-181.
25. Mahowald M.W., Bundlie S.R., Hurwitz T.D., et al. Sleep violence forensic-science implications-polygraphic and video documentation. J Forensic Sci 1990, 35(2):413-432.
26. Kotagal S. Parasomnias of childhood. Curr Opin Pediatr 2008, 20(6):659-665.
27. Kales A., Soldatos C.R., Bixler E.O., et al. Hereditary factors in sleepwalking and night terrors. Br J Psychiatry 1980, 137:111-118.
28. Bakwin H. Sleep-walking in twins. Lancet 1970, 2(7670):446-447.
29. Broughton RJ. Parasomnias. In: Chokroverty S, editor. Sleep disorders medicine 1994. p. 381-99.
30. Lecendreux M., Bassetti C., Dauvilliers Y., et al. HLA and genetic susceptibility to sleepwalking. Mol Psychiatry 2003, 8(1):114-117.
31. Espa F., Ondze B., Deglise P., et al. Sleep architecture, slow wave activity, and sleep spindles in adult patients with sleepwalking and sleep terrors. Clin Neurophysiol 2000, 111(5):929-939.
32. Guilleminault C., Poyares D., Abat F., et al. Sleep and wakefulness in somnambulism: a spectral analysis study. J Psychosom Res 2001, 51(2):411-416.
33. Gaudreau H., Joncas S., Zadra A., et al. Dynamics of slow-wave activity during the NREM sleep of sleepwalkers and control subjects. Sleep 2000, 23(6):755-760.
34. Szelenberger W., Niemcewicz S., Dabrowska A.J. Sleepwalking and night terrors: psychopathological and psychophysiological correlates. Int Rev Psychiatry 2005, 17(4):263-270.
35. Bassetti C., Vella S., Donati F., et al. SPECT during sleepwalking. Lancet 2000, 356(9228):484-485.
36. Crisp A.H. The sleepwalking/night terrors syndrome in adults. Postgrad Med J 1996, 72(852):599-604.
37. Pressman M.R. Disorders of arousal from sleep and violent behavior: the role of physical contact and proximity. Sleep 2007, 30(8):1039-1047.
38. Mahowald M.W., Schenck C.H., Goldner M., et al. Parasomnia pseudo-suicide. J Forensic Sci 2003, 48(5):1158-1162.
39. Rosen G., Mahowald M.W., Ferber R. Sleepwalking, confusional arousals, and sleep terrors in the child. Principles and practice of sleep medicine in the child.1995 1995, 99-106.
40. Arkin A.M. Sleep-talking: a review. J Nerv Ment Dis 1966, 143(2):101-122.
41. Liu X., Ma Y., Wang Y., et al. Brief report: an epidemiologic survey of the prevalence of sleep disorders among children 2 to 12 years old in Beijing, China. Pediatrics 2005, 115(1 Suppl):266-268.
42. Bae C.J., Lee J.K., Foldvary-Schaefer N. The use of sleep studies in neurologic practice. Semin Neurol 2009, 29(4):305-319.
43. Derry C.P., Duncan J.S., Berkovic S.F. Paroxysmal motor disorders of sleep: the clinical spectrum and differentiation from epilepsy. Epilepsia 2006, 47(11):1775-1791.
44. Derry C.P., Davey M., Johns M., et al. Distinguishing sleep disorders from seizures: diagnosing bumps in the night. Arch Neurol 2006, 63(5):705-709.
45. Ryvlin P., Rheims S., Risse G. Nocturnal frontal lobe epilepsy. Epilepsia 2006, 47(Suppl 2):83-86.
46. Malow B.A. Sleep and epilepsy. Neurol Clin 2005, 23(4):1127-1147.
47. Bazil C.W. Nocturnal seizures. Semin Neurol 2004, 24(3):293-300.
48. Provini F., Plazzi G., Tinuper P., et al. Nocturnal frontal lobe epilepsy: a clinical and polygraphic overview of 100 consecutive cases. Brain 1999, 122(6):1017-1031.
49. Herman S.T. Epilepsy and sleep. Curr Treat Options Neurol 2006, 8(4):271-279.
50. American Sleep Disorders Association International classification of sleep disorders: diagnostic and coding manual 1997, American Sleep Disorders Association, Rochester (MN).
51. Sellal F., Hirsch E. Nocturnal paroxysmal dystonia. Mov Disord 1993, 8(2):252-253.
52. Bhatia K.P. The paroxysmal dyskinesias. J Neurol 1999, 246(3):149-155.
53. Levin R., Fireman G. Nightmare prevalence, nightmare distress, and self-reported psychological disturbance. Sleep 2002, 25(2):205-212.
54. Nguyen T.T., Madrid S., Marquez H., et al. Nightmare frequency, nightmare distress, and anxiety. Percept Mot Skills 2002, 95(1):219-225.
55. Woodward S.H., Arsenault N.J., Murray C., et al. Laboratory sleep correlates of nightmare complaint in PTSD inpatients. Biol Psychiatry 2000, 48(11):1081-1087.
56. Mahowald MW, Schenck CH. NREM sleep parasomnias 1996;14(4):675-96.
57. Aldrich M.S. Sleep medicine 1999, vol. 53. Oxford University Press, Inc, Oxford New York USA.
58. Wise M.S. Parasomnias in children. Pediatr Ann 1997, 26(7):427-433.
59. Penn N.E., Kripke D.F., Scharff J. Sleep paralysis among medical students. J Psychol 1981, 107(Pt 2):247-252.
60. Buzzi G., Cirignotta F. Isolated sleep paralysis: a web survey. Sleep Res Online 2000, 3(2):61-66.
61. Snyder S., Hams G. Serotoninergic agents in the treatment of isolated sleep paralysis. Am J Psychiatry 1982, 139(9):1202-1203.
62. Koran L.M., Raghavan S. Fluoxetine for isolated sleep paralysis. Psychosomatics 1993, 34(2):184-187.
63. Schenck C.H., Mahowald M.W. Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients. Cleve Clin J Med 1990, 57(Suppl):s9-23.
64. Mahowald M.W., Schenck C.H. REM sleep behavior disorder. Handbook of sleep disorders 1990, 567-593. Marcel Dekker, New York. M.J. Thorpy (Ed.).
65. Schenck C.H., Hurwitz T.D., Mahowald M.W. REM sleep behavior disorder. Am J Psychiatry 1988, 145(5):652.
66. Abad V.C., Guilleminault C. Review of rapid eye movement behavior sleep disorders. Curr Neurol Neurosci Rep 2004, 4(2):157-163.
67. Ozekmekci S., Apaydin H., Kilic E. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder. Clin Neurol Neurosurg 2005, 107(4):306-309.
68. Schenck C.H., Bundlie S.R., Patterson A.L., et al. Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. JAMA 1987, 257(13):1786-1789.
69. Comella C.L., Nardine T.M., Diederich N.J., et al. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 1998, 51:526-529.
70. Eisehsehr I., Parrino L., Noachtar S., et al. Sleep in Lennox-Gastaut syndrome: the role of the cyclic alternating pattern (CAP) in the gate control of clinical seizures and generalized polyspikes. Epilepsy Res 2001, 46:241-250.
71. Tachibana M., Tanaka K., Hishikawa Y., et al. A sleep study of acute psychotic states due to alcohol and meprobamate addiction. Adv Sleep Res 1975, 2:177-205.
72. Passouant P., Cadilhac J., Ribstein M. Les privations de sommeil avec mouvements oculaires par les anti-depresseurs [Sleep privation with eye movements using antidepressive agents]. Rev Neurol 1972, 127:173-192. [in French].
73. Guilleminault C., Raynal D., Takahashi S., et al. Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride. Acta Neurol Scand 1976, 54:71-87.
74. Besset A. Effect of antidepressants on human sleep. Adv Biosci 1978, 21:141-148.
75. Shimizu T., Ookawa M., Iijuma S., et al. Effect of clomipramine on nocturnal sleep of normal human subjects. Annu Rev Pharmacopsychiat Res Found 1985, 16:138.
76. Bental E., Lavie P., Sharf B. Severe hypermotility during sleep in treatment of cataplexy with clomipramine. Isr J Med Sci 1979, 15:607-609.
77. Akindele M.O., Evans J.I., Oswald I. Mono-amine oxidase inhibitors, sleep and mood. Electroencephalogr Clin Neurophysiol 1970, 29:47-56.
78. Carlander B., Touchon J., Ondze B., et al. REM sleep behavior disorder induced by cholinergic treatment in Alzheimer's disease. J Sleep Res 1996, 5(Suppl 1):28.
79. Ross J.S., Shua-Haim J.R. Aricept-induced nightmares in Alzheimer's disease: 2 case reports. J Am Geriatr Soc 1998, 46:119-120.
80. Schenck C.H., Mahowald M.W., Kim S.W., et al. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 1992, 15:226-235.
81. Schutte S., Doghramji K. REM behavior disorder seen with venlafaxine (Effexor). Sleep Res 1996, 25:364.
82. Stolz S.E., Aldrich M.S. REM sleep behavior disorder associated with caffeine abuse. Sleep Res 1991, 20:341.
83. Vorona R.D., Ware J.C. Exacerbation of REM sleep behavior disorder by chocolate ingestion: a case report. Sleep Med 2002, 3:365-367.
84. Friedman J.H. Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3). Mov Disord 2002, 17(6):1350-1353.
85. Xi Z., Luning W. REM sleep behavior disorder in a patient with pontine stroke. Sleep Med 2009, 10(1):143-146.
86. Schenck C.H., Mahowald M.W. Rapid eye movement sleep parasomnias. Neurol Clin 2005, 23(4):1107-1126.
87. Plazzi G., Montagna P. Remitting REM sleep behavior disorder as the initial sign of multiple sclerosis. Sleep Med 2002, 3(5):437-439.
88. Arnulf I., Merino-Andreu M., Bloch F., et al. REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep 2005, 28(3):349-354.
89. Gagnon J.F., Petit D., Fantini M.L., et al. REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease. Sleep 2006, 29(10):1321-1325.
90. Pareja J.A., Caminero A.B., Masa J.F., et al. A first case of progressive supranuclear palsy and pre-clinical REM sleep behavior disorder presenting as inhibition of speech during wakefulness and somniloquy with phasic muscle twitching during REM sleep. Neurologia 1996, 11:304-306.
91. Boeve B.F., Silber M.H., Ferman J.T., et al. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001, 16:622-630.
92. Boeve B.F., Silber M.H., Parisi J.E., et al. Synucleinopathy pathology often underlies REM sleep behavior disorder and dementia or parkinsonism. Neurology 2003, 61:40-45.
93. Schenck C.H., Bundlie S.R., Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996, 46:388-393.
94. Montplaisir J., Petit D., Decary A., et al. Sleep and quantitative EEG in patients with progressive supranuclear palsy. Neurology 1997, 49:999-1003.
95. Nevsimalova S., Prihodova I., Kemlink D., et al. REM behavior disorder (RBD) can be one of the first symptoms of childhood narcolepsy. Sleep Med 2007, 8(7-8):784-786.
96. Schenck C.H., Mahowald M.W. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol 1992, 32:3-10.
97. Jouvet M., Delorme F. Locus coeruleus et sommeil paradoxal. C R Soc Biol 1965, 159:895-899.
98. Schenck C.H., Bundlie S.R., Ettinger M.G., et al. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986, 9:293-308.
99. Paparrigopoulos T.J. REM sleep behaviour disorder: clinical profiles and pathophysiology. Int Rev Psychiatry 2005, 17(4):293-300.
100. Mahowald M., Schenck C. REM sleep parasomnias. Principles and practice of sleep medicine 2000, 724-737. W.B. Saunders, Philadelphia. 3rd edition. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
101. Eisensehr I., Linke R., Noachtar S., et al. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behavior disorder. Comparison with Parkinson's disease and controls. Brain 2000, 123:1155-1160.
102. Eisehsehr I., Linke R., Tatsch K., et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 2003, 26:507-512.
103. Albin R.L., Koeppe R.A., Chervin R.D., et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000, 55:1410-1412.
104. Gilman S., Koeppe R.A., Chervin R., et al. REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology 2003, 61:29-34.
105. Iranzo A., Santamaria J., Tolosa E. The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev 2009, 13(6):385-401.
106. Fantini M.L., Gagnon J.F., Petit D., et al. Slowing of electroencephalogram in rapid eye movement sleep behavior disorder. Ann Neurol 2003, 53(6):774-780.
107. Raffaele M., Michele T., Alessandra R. The FLEP scale in diagnosing nocturnal frontal lobe epilepsy, NREM and REM parasomnias: data from a tertiary sleep and epilepsy unit. Epilepsia 2008, 49(9):1581-1585.
108. Schenck C.H., Mahowald M.W. REM parasomnias. Neurol Clin 1996, 14:697-720.
109. Schenck C.H., Mahowald M.W. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002, 25(2):120-138.
110. Mahowald M.W. Parasomnias. Med Clin North Am 2004, 88(3):669-678. ix.
111. Bonakis A., Howard R.S., Ebrahim I.O., et al. REM sleep behaviour disorder (RBD) and its associations in young patients. Sleep Med 2009, 10(6):641-645.
112. Stores G. Rapid eye movement sleep behaviour disorder in children and adolescents. Dev Med Child Neurol 2008, 50(10):728-732.
113. Schenck C.H., Mahowald M.W. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 1996, 100(3):333-337.
114. Balon R. Sleep terror disorder and insomnia treated with trazodone: a case report. Ann Clin Psychiatry 1994, 6(3):161-163.
115. Lillywhite A.R., Wilson S.J., Nutt D.J. Successful treatment of night terrors and somnambulism with paroxetine. Br J Psychiatry 1994, 164(4):551-554.
116. Guilleminault C., Kirisoglu C., Bao G., et al. Adult chronic sleepwalking and its treatment based on polysomnography. Brain 2005, 128(5):1062-1069.
117. Sadeh A. Cognitive-behavioral treatment for childhood sleep disorders. Clin Psychol Rev 2005, 25(5):612-628.
118. Hurwitz T.D., Mahowald M.W., Schenck C.H., et al. A retrospective outcome study and review of hypnosis as treatment of adults with sleepwalking and sleep terror. J Nerv Ment Dis 1991, 179(4):228-233.
119. Tobin J.D. Treatment of somnambulism with anticipatory awakening. J Pediatr 1993, 122(3):426-427.
120. Mahowald M.W., Schenck C.H. REM sleep behavior disorder 1994, WB Saunders, Philadelphia.
121. Lapierre O., Montplaisir J. Polysomnographic features of REM sleep behavior disorder: Development of a scoring method. Neurology 1992, 42:1371-1374.
122. Takeuchi N., Uchimura N., Hashizume Y., et al. Melatonin therapy for REM sleep behavior disorder. Psychiatry Clin Neurosci 2001, 55(3):267-269.
123. Boeve B. Melatonin for treatment of REM sleep behavior disorder: response in 8 patients. Sleep 2001, 24(Suppl):A35.
124. Schmidt M.H., Koshal V.B., Schmidt H.S. Use of pramipexole in REM sleep behavior disorder: results from a case series. Sleep Med 2006, 7(5):418-423.
125. Fantini M.L., Gagnon J.-F., Filipini D., et al. The effects of pramipexole in REM sleep behavior disorder. Neurology 2003, 61:1418-1420.
126. Tan A., Salgado M., Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Mov Disord 1996, 11(2):214-216.
127. Shneerson J.M. Successful treatment of REM sleep behavior disorder with sodium oxybate. Clin Neuropharmacol 2009, 32(3):158-159.